-
1041
Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case
Published 2023-01-01Get full text
Article -
1042
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements
Published 2023-10-01“…All the studies within the systematic review were clinical trials spanning from 1995 to 2023, involving 6383 patients. Neuro-oncology published the most glioma immunotherapy-related clinical trials (15/97, 16%). …”
Get full text
Article -
1043
FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial
Published 2022-11-01“…There are multiple other surgical adjuncts available to the neuro-oncology surgeon. However, access to, and usage of these varies widely in UK practice, with limited evidence of their use. …”
Get full text
Article -
1044
-
1045
Neurosurgical Defeats: Critically Ill Patients and the Role of Palliative Care Service
Published 2022-09-01“…The onco-functional balance in neuro-oncology requires maximizing tumor removal while rigorously preserving patients’ neurological status. …”
Get full text
Article -
1046
-
1047
-
1048
-
1049
-
1050
Concurrent Presence of Thoracolumbar Scoliosis and Chiari Malformation: Is Operative Risk Magnified?
Published 2023-08-01Get full text
Article -
1051
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada
Published 2024-02-01Get full text
Article -
1052
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors
Published 2022-04-01Get full text
Article -
1053
-
1054
2252
Published 2017-09-01“…“Loss to follow up” was defined as failure to attend follow-up appointments with neurosurgery, radiation oncology, or neuro-oncology within a year of the most recent assigned follow-up interval, as recorded in the electronic medical record. …”
Get full text
Article -
1055
Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma
Published 2022-12-01“…Tumor delineation on the initial MRI 1 (GTV 1), post-RT-CT NADIR MRI 2 (GTV 2), and progression MRI 3 (GTV 3) were performed semi-automatically and manually adjusted by a neuroradiologist specialist in neuro-oncology. GTV 2 and GTV 3 were then co-registered on FET PET data. …”
Get full text
Article -
1056
-
1057
Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
Published 2022-11-01“…Local failure determination was based on SPIne response assessment in Neuro-Oncology criteria. RM was defined as neurologic symptoms consistent with the segment of cord irradiated in the absence of neoplastic disease recurrence and graded by Common Toxicity Criteria for Adverse Events, version 4.0. …”
Get full text
Article -
1058
The effect of the Dar es Salaam neurosurgery training course on self-reported neurosurgical knowledge and confidence
Published 2023-01-01“…These included neurovascular, neuro-oncology, and minimally invasive spine surgery topics. …”
Get full text
Article -
1059
-
1060
MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
Published 2020-04-01Get full text
Article